{"id":{"repo_id":"etsu","oai_identifier":"oai:dc.etsu.edu:etd-6350"},"canonical_url":"https://search.ndltd.org/etd/etsu/oai:dc.etsu.edu:etd-6350","repository":{"repo_id":"etsu","name":"East Tennessee State University","base_url":"https://dc.etsu.edu/do/oai/"},"display":{"title":"What is Known about the Gut Microbiome and Dietary Factors in Amyotrophic Lateral Sclerosis? A Scoping Review","abstract":"Introduction/Background: Amyotrophic Lateral Sclerosis (ALS) is a progressive motor neuron disease that currently has no cure. It causes multi-system dysfunction, leads to neuron/cell apoptosis, paralysis, respiratory failure, and death of the person living with ALS (PALS). Due to the gut microbiome’s role in immunity/inflammation and the gut-brain axis, it stands to reason that dietary interventions that positively impact the gut may aid in ALS symptom management. This scoping review examines what is known about the relationship between the gut microbiome in PALS and how dietary and metabolic factors may influence the microbiota and disease process. Methods: PRISMA-ScR guidelines used for synthesis and reporting of literature. Results/Conclusion: Some supplements and diet interventions may have a positive benefit for PALS, however, evidence is lacking to determine the benefit of these interventions in humans. High quality, large-scale, longitudinal surveys and randomized control trials are needed in this area of research.","abstract_html":"Introduction/Background: Amyotrophic Lateral Sclerosis (ALS) is a progressive motor neuron disease that currently has no cure. It causes multi-system dysfunction, leads to neuron/cell apoptosis, paralysis, respiratory failure, and death of the person living with ALS (PALS). Due to the gut microbiome’s role in immunity/inflammation and the gut-brain axis, it stands to reason that dietary interventions that positively impact the gut may aid in ALS symptom management. This scoping review examines what is known about the relationship between the gut microbiome in PALS and how dietary and metabolic factors may influence the microbiota and disease process. Methods: PRISMA-ScR guidelines used for synthesis and reporting of literature. Results/Conclusion: Some supplements and diet interventions may have a positive benefit for PALS, however, evidence is lacking to determine the benefit of these interventions in humans. High quality, large-scale, longitudinal surveys and randomized control trials are needed in this area of research.","abstract_has_math":false,"creators":["Boydston, Christina L"],"institution":"East Tennessee State University","degree_name":"MS (Master of Science)","degree_level":"Dissertation - unrestricted","degree_discipline":"Clinical Nutrition","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026-12-01T08:00:00Z","date_published":"2026-12-01T08:00:00Z","updated_at":"2026-11-20T07:59:32Z","subjects":["microbiome","Amyotrophic Lateral Sclerosis","ALS","microbiota","fiber","probiotic","prebiotic","ketogenic diet","antioxidant","Dietetics and Clinical Nutrition","Disorders of Environmental Origin","Human and Clinical Nutrition","Nervous System Diseases"],"languages":["eng"],"rights":["Copyright by the authors."],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dc.etsu.edu/etd/4784","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dc.etsu.edu/etd/4784","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":"https://dc.etsu.edu/context/etd/article/6350/viewcontent/BoydstonC111726f.pdf","download_label":"Download PDF","download_source":"dc:identifier","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dc.etsu.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adc.etsu.edu%3Aetd-6350","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Boydston, Christina L"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2026-11-06T08:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2026-12-01T08:00:00Z"]},{"key":"dc:publisher","label":"Institution","values":["East Tennessee State University"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Clinical Nutrition"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation - unrestricted"]},{"key":"thesis:degree_name","label":"Degree Name","values":["MS (Master of Science)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["East Tennessee State University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["microbiome","Amyotrophic Lateral Sclerosis","ALS","microbiota","fiber","probiotic","prebiotic","ketogenic diet","antioxidant","Dietetics and Clinical Nutrition","Disorders of Environmental Origin","Human and Clinical Nutrition","Nervous System Diseases"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["Copyright by the authors."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dc.etsu.edu/context/etd/article/6350/viewcontent/BoydstonC111726f.pdf","https://dc.etsu.edu/etd/4784"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Introduction/Background: Amyotrophic Lateral Sclerosis (ALS) is a progressive motor neuron disease that currently has no cure. It causes multi-system dysfunction, leads to neuron/cell apoptosis, paralysis, respiratory failure, and death of the person living with ALS (PALS). Due to the gut microbiome’s role in immunity/inflammation and the gut-brain axis, it stands to reason that dietary interventions that positively impact the gut may aid in ALS symptom management. This scoping review examines what is known about the relationship between the gut microbiome in PALS and how dietary and metabolic factors may influence the microbiota and disease process. Methods: PRISMA-ScR guidelines used for synthesis and reporting of literature. Results/Conclusion: Some supplements and diet interventions may have a positive benefit for PALS, however, evidence is lacking to determine the benefit of these interventions in humans. High quality, large-scale, longitudinal surveys and randomized control trials are needed in this area of research."]},{"key":"dc:title","label":"Title","values":["What is Known about the Gut Microbiome and Dietary Factors in Amyotrophic Lateral Sclerosis? A Scoping Review"]}]}],"canonical_facts":{"dc:creator":["Boydston, Christina L"],"dc:date.available":["2026-11-06T08:00:00Z"],"dc:date.issued":["2026-12-01T08:00:00Z"],"dc:description.abstract":["Introduction/Background: Amyotrophic Lateral Sclerosis (ALS) is a progressive motor neuron disease that currently has no cure. It causes multi-system dysfunction, leads to neuron/cell apoptosis, paralysis, respiratory failure, and death of the person living with ALS (PALS). Due to the gut microbiome’s role in immunity/inflammation and the gut-brain axis, it stands to reason that dietary interventions that positively impact the gut may aid in ALS symptom management. This scoping review examines what is known about the relationship between the gut microbiome in PALS and how dietary and metabolic factors may influence the microbiota and disease process. Methods: PRISMA-ScR guidelines used for synthesis and reporting of literature. Results/Conclusion: Some supplements and diet interventions may have a positive benefit for PALS, however, evidence is lacking to determine the benefit of these interventions in humans. High quality, large-scale, longitudinal surveys and randomized control trials are needed in this area of research."],"dc:identifier":["https://dc.etsu.edu/context/etd/article/6350/viewcontent/BoydstonC111726f.pdf","https://dc.etsu.edu/etd/4784"],"dc:language":["eng"],"dc:publisher":["East Tennessee State University"],"dc:rights":["Copyright by the authors."],"dc:subject":["microbiome","Amyotrophic Lateral Sclerosis","ALS","microbiota","fiber","probiotic","prebiotic","ketogenic diet","antioxidant","Dietetics and Clinical Nutrition","Disorders of Environmental Origin","Human and Clinical Nutrition","Nervous System Diseases"],"dc:title":["What is Known about the Gut Microbiome and Dietary Factors in Amyotrophic Lateral Sclerosis? A Scoping Review"],"thesis:degree_discipline":["Clinical Nutrition"],"thesis:degree_level":["Dissertation - unrestricted"],"thesis:degree_name":["MS (Master of Science)"],"thesis:institution_name":["East Tennessee State University"]},"updated_at":"2026-11-20T07:59:32Z"}